913 related articles for article (PubMed ID: 28551069)
41. Sphingolipids in macroautophagy.
Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
Methods Mol Biol; 2008; 445():159-73. PubMed ID: 18425450
[TBL] [Abstract][Full Text] [Related]
42. Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.
Realini N; Palese F; Pizzirani D; Pontis S; Basit A; Bach A; Ganesan A; Piomelli D
J Biol Chem; 2016 Jan; 291(5):2422-34. PubMed ID: 26553872
[TBL] [Abstract][Full Text] [Related]
43. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
[TBL] [Abstract][Full Text] [Related]
44. Sphingolipid metabolism and its role in the skeletal tissues.
Khavandgar Z; Murshed M
Cell Mol Life Sci; 2015 Mar; 72(5):959-69. PubMed ID: 25424644
[TBL] [Abstract][Full Text] [Related]
45. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
46. The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and sphingolipid metabolism.
Siow D; Wattenberg B
Crit Rev Biochem Mol Biol; 2011 Oct; 46(5):365-75. PubMed ID: 21864225
[TBL] [Abstract][Full Text] [Related]
47. Sphingolipid metabolizing enzymes as novel therapeutic targets.
Billich A; Baumruker T
Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
[TBL] [Abstract][Full Text] [Related]
48. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
49. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
Lee JY; Jin HK; Bae JS
BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
[TBL] [Abstract][Full Text] [Related]
50. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
51. [Transcriptional regulation of sphingolipid metabolic enzymes].
Murate T
Seikagaku; 2007 Dec; 79(12):1139-43. PubMed ID: 18203454
[No Abstract] [Full Text] [Related]
52. Sphingosine kinase localization in the control of sphingolipid metabolism.
Siow DL; Anderson CD; Berdyshev EV; Skobeleva A; Natarajan V; Pitson SM; Wattenberg BW
Adv Enzyme Regul; 2011; 51(1):229-44. PubMed ID: 21075134
[TBL] [Abstract][Full Text] [Related]
53. Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue.
Kolak M; Gertow J; Westerbacka J; Summers SA; Liska J; Franco-Cereceda A; Orešič M; Yki-Järvinen H; Eriksson P; Fisher RM
Lipids Health Dis; 2012 Sep; 11():115. PubMed ID: 22974251
[TBL] [Abstract][Full Text] [Related]
54. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
Gencer EB; Ural AU; Avcu F; Baran Y
Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
[TBL] [Abstract][Full Text] [Related]
55. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
56. Enzymes of sphingolipid metabolism: from modular to integrative signaling.
Hannun YA; Luberto C; Argraves KM
Biochemistry; 2001 Apr; 40(16):4893-903. PubMed ID: 11305904
[TBL] [Abstract][Full Text] [Related]
57. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
Morad SA; Cabot MC
Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
[TBL] [Abstract][Full Text] [Related]
58. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
59. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid.
Kim JL; Mestre B; Shin SH; Futerman AH
Cell Signal; 2021 Jun; 82():109958. PubMed ID: 33607256
[TBL] [Abstract][Full Text] [Related]
60. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
Nixon GF
Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
